159 related articles for article (PubMed ID: 28598516)
1. Intratumor cisplatin nephrotoxicity in combined laser-induced thermal therapy for cancer treatment.
Palumbo MN; Cervantes O; Eugênio C; Hortense FTP; Ribeiro JC; Paolini AAP; Tedesco AC; Sercarz JA; Paiva MB
Lasers Surg Med; 2017 Oct; 49(8):756-762. PubMed ID: 28598516
[TBL] [Abstract][Full Text] [Related]
2. Intratumor injections of cisplatin and laser thermal therapy for palliative treatment of recurrent cancer.
Paiva MB; Bublik M; Castro DJ; Udewitz M; Wang MB; Kowalski LP; Sercarz J
Photomed Laser Surg; 2005 Dec; 23(6):531-5. PubMed ID: 16356142
[TBL] [Abstract][Full Text] [Related]
3. Combined cisplatinum and laser thermal therapy for palliation of recurrent head and neck tumors.
Paiva MB; Saxton RE; Blackwell KE; Buechler P; Cohen A; Liu CD; Calcaterra TC; Ward PH; Castro DJ
Diagn Ther Endosc; 2000; 6(3):133-40. PubMed ID: 18493516
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral cisplatin/epinephrine gel in advanced head and neck cancer: a multicenter, randomized, double-blind, phase III study in North America.
Castro DJ; Sridhar KS; Garewal HS; Mills GM; Wenig BL; Dunphy FR; Costantino PD; Leavitt RD; Stewart ME; Orenberg EK
Head Neck; 2003 Sep; 25(9):717-31. PubMed ID: 12953307
[TBL] [Abstract][Full Text] [Related]
5. Combined intratumor cisplatinum injection and Nd:YAG laser therapy.
Graeber IP; Eshraghi AA; Paiva MB; Paek WH; Castro DJ; Jovanovic S; Scherer H; Soudant J; Saxton RE
Laryngoscope; 1999 Mar; 109(3):447-54. PubMed ID: 10089974
[TBL] [Abstract][Full Text] [Related]
6. Retention of intratumor injections of cisplatinum in murine tumors and the impact on laser thermal therapy for cancer treatment.
Kanekal S; Joo J; Bublik M; Bababeygy A; Loh C; Castro DJ; Sercarz JA; Paiva MB
Eur Arch Otorhinolaryngol; 2009 Feb; 266(2):279-84. PubMed ID: 18607614
[TBL] [Abstract][Full Text] [Related]
7. Phase I trial of concurrent hyperfractionated split course radiotherapy (HFx RT), cisplatin (cDDP), and paclitaxel in patients with recurrent, previously irradiated, or treatment-naïve locally advanced upper aerodigestive malignancy.
Langer CJ; Duffy K; Horwitz EM; Litwin S; Rosvold E; Schol J; Keenan E; Nicolaou N; Friedman CD; Ridge JA
Cancer Invest; 2006 Mar; 24(2):164-73. PubMed ID: 16537186
[TBL] [Abstract][Full Text] [Related]
8. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
[TBL] [Abstract][Full Text] [Related]
9. Relationship between pharmacokinetics of unchanged cisplatin and nephrotoxicity after intravenous infusions of cisplatin to cancer patients.
Nagai N; Kinoshita M; Ogata H; Tsujino D; Wada Y; Someya K; Ohno T; Masuhara K; Tanaka Y; Kato K; Nagai H; Yokoyama A; Kurita Y
Cancer Chemother Pharmacol; 1996; 39(1-2):131-7. PubMed ID: 8995510
[TBL] [Abstract][Full Text] [Related]
10. Laser and cisplatinum for treatment of human squamous cell carcinoma.
Paiva MB; Graeber IP; Castro DJ; Suh MJ; Paek WH; Eshraghi AA; Saxton RE
Laryngoscope; 1998 Sep; 108(9):1269-76. PubMed ID: 9738740
[TBL] [Abstract][Full Text] [Related]
11. Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer.
Buglione M; Maddalo M; Corvò R; Pirtoli L; Paiar F; Lastrucci L; Stefanacci M; Belgioia L; Crociani M; Vecchio S; Bonomo P; Bertocci S; Borghetti P; Pasinetti N; Triggiani L; Costa L; Tonoli S; Grisanti S; Magrini SM
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):462-472. PubMed ID: 27986347
[TBL] [Abstract][Full Text] [Related]
12. Phase 2 study of intratumoral cisplatin and epinephrine treatment for locally recurrent head and neck tumors.
Duvillard C; Romanet P; Cosmidis A; Beaudouin N; Chauffert B
Ann Otol Rhinol Laryngol; 2004 Mar; 113(3 Pt 1):229-33. PubMed ID: 15053208
[TBL] [Abstract][Full Text] [Related]
13. Laser-induced thermal therapy and cisplatin for recurrent head and neck cancer: a case characterized by an unusually long disease-free survival.
Joo J; Sercarz JA; Paolini AA; Castro DJ; Paiva MB
Ear Nose Throat J; 2009 Nov; 88(11):E13-6. PubMed ID: 19924650
[TBL] [Abstract][Full Text] [Related]
14. Cisplatinum and interstitial laser therapy for advanced head and neck cancer: a preclinical study.
Paiva MB; Saxton RE; VanderWerf QM; Bell T; Eshraghi AA; Graeber IP; Feyh J; Castro DJ
Lasers Surg Med; 1997; 21(5):423-31. PubMed ID: 9365952
[TBL] [Abstract][Full Text] [Related]
15. Selective high-dose intra-arterial cisplatin as palliative treatment for incurable head and neck cancer.
Teymoortash A; Bien S; Dalchow C; Sesterhenn A; Lippert BM; Werner JA
Onkologie; 2004 Dec; 27(6):547-51. PubMed ID: 15591713
[TBL] [Abstract][Full Text] [Related]
16. The Rationale for "Laser-Induced Thermal Therapy (LITT) and Intratumoral Cisplatin" Approach for Cancer Treatment.
de Brito RV; Mancini MW; Palumbo MDN; Moraes LHO; Rodrigues GJ; Cervantes O; Sercarz JA; Paiva MB
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682611
[TBL] [Abstract][Full Text] [Related]
17. [Measurement of creatinine clearance and urinary NAG for the evaluation of cis-platinum induced nephrotoxicity].
Kubota A; Yoshida T; Tsukuda M; Furukawa S; Miyata K; Mochimatsu I; Sawaki S
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2599-605. PubMed ID: 2774590
[TBL] [Abstract][Full Text] [Related]
18. Degree of nephrotoxicity after intermediate- or high-dose cisplatin-based chemoradiotherapy in patients with locally advanced head and neck cancer.
Driessen CM; Uijen MJ; van der Graaf WT; van Opstal CC; Kaanders JH; Nijenhuis T; van Herpen CM
Head Neck; 2016 Apr; 38 Suppl 1():E1575-81. PubMed ID: 26614010
[TBL] [Abstract][Full Text] [Related]
19. MRI-guided laser interstitial thermal therapy (LITT) of head and neck tumors: progress with a new method.
Feyh J; Gutmann R; Leunig A; Jäger L; Reiser M; Saxton RE; Castro DJ; Kastenbauer E
J Clin Laser Med Surg; 1996 Dec; 14(6):361-6. PubMed ID: 9467326
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
